Tuberculous meningitis: more questions, still too few answers (Q38131175)

29 August 2017

title

Tuberculous meningitis: more questions, still too few answers (English)

1 reference

29 August 2017

1 reference

tuberculous meningitis

1 reference

Guy E Thwaites

0 references

Ronald van Toorn

1 reference

29 August 2017

Johan Schoeman

series ordinal

1 reference

29 August 2017

publication date

23 August 2013

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

999-1010

1 reference

Tuberculous meningitis: many questions, too few answers

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Scaling up interventions to achieve global tuberculosis control: progress and new developments

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculosis in the UK--time to regain control

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The changing profile of pediatric meningitis at a referral centre in Cape Town, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculosis vaccines: beyond bacille Calmette-Guerin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Seasonal variation in the incidence rate of tuberculous meningitis is associated with sunshine hours

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Accelerated detection of Mycobacterium tuberculosis genes essential for bacterial survival in guinea pigs, compared with mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Murine model to study the invasion and survival of Mycobacterium tuberculosis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous meningitis in children. A review of 167 untreated and 74 treated patients with special reference to early diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The 'Road to Health' card in tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculosis of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Absence of an association between Mycobacterium tuberculosis genotype and clinical features in children with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Impact of Drug Resistance on Clinical Outcome in Children With Tuberculous Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous meningitis in BCG vaccinated and unvaccinated children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Impact of bacille Calmette-Guérin vaccination on neuroradiological manifestations of pediatric tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

A diagnostic rule for tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Differentiation of tuberculous meningitis from acute bacterial meningitis using simple clinical and laboratory parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Clinical prediction rule for differentiating tuberculous from viral meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Validation of diagnostic algorithm to differentiate between tuberculous meningitis and acute bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Comparison of a clinical prediction rule and a LAM antigen-detection assay for the rapid diagnosis of TBM in a high HIV prevalence setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Thwaites' diagnostic scoring and the prediction of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Validation of a diagnostic algorithm for adult tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Sensitivity and specificity of an index for the diagnosis of TB meningitis in patients in an urban teaching hospital in Malawi

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The bacteriological diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Improving the bacteriological diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

A highly efficient Ziehl-Neelsen stain: identifying de novo intracellular Mycobacterium tuberculosis and improving detection of extracellular M. tuberculosis in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Novel technique of quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Novel wide-range quantitative nested real-time PCR assay for Mycobacterium tuberculosis DNA: development and methodology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Comparison of real time IS6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Diagnosis of tuberculous meningitis: clinical and laboratory parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Efficient diagnosis of tuberculous meningitis by detection of Mycobacterium tuberculosis DNA in cerebrospinal fluid filtrates using PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

T-cell-based assays on cerebrospinal fluid and PBMCs for rapid diagnosis of TB meningitis in non-HIV patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Multidrug-resistant tuberculous meningitis in children in Durban, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Evaluation of the MODS culture technique for the diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Reliability and diagnostic performance of CT imaging criteria in the diagnosis of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Definitive neuroradiological diagnostic features of tuberculous meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Brainstem ischemic lesions on MRI in children with tuberculous meningitis: with diffusion weighted confirmation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Magnetic resonance imaging of miliary tuberculosis of the central nervous system in children with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

MR angiography in tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculosis of the central nervous system: overview of neuroradiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The diagnosis of brain tuberculoma by 1H-magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The chemotherapy of tuberculous meningitis in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Safety concerns with fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Home-based treatment of childhood neurotuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Evidence behind the WHO guidelines: hospital care for children: what is the most appropriate anti-microbial treatment for tuberculous meningitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Corticosteroids for managing tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The Role of Aspirin in Childhood Tuberculous Meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Neurological manifestations of TB-IRIS: a report of 4 children.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Adjuvant interferon-γ treatment in two cases of refractory tuberculosis of the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Serial CT Scanning in Childhood Tuberculous Meningitis: Prognostic Features in 198 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Central nervous system tuberculosis in children: a review of 214 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Serial lumbar CSF presure measurements and cranial computed tomographic findings in childhood tuberculous meningitits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Intracranial pressure monitoring in tuberculous meningitis: clinical and computerized tomographic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Can CT predict the level of CSF block in tuberculous hydrocephalus?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Ventriculoperitoneal shunting in childhood tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Pneumoencephalography in tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Use of endoscopic third ventriculostomy in hydrocephalus of tubercular origin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Endoscopy for tuberculous hydrocephalus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Endoscopic third ventriculostomy in tuberculous meningitis needs more evidence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous cerebrovascular disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Coagulant and fibrinolytic status in tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Cerebral infarction and neurodevelopmental outcome in childhood tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Clinical characteristics and treatment delay of cerebral infarction in tuberculous meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Tuberculous granulomas in childhood tuberculous meningitis: radiological features and course

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

Management of the immune reconstitution inflammatory syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2813%2970168-6

7 January 2021

10.1016/S1474-4422(13)70168-6

Identifiers

DOI

1 reference

29 August 2017

1 reference